Plasma Exchange With Albumin in AMN Patients

NCT04303416 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

5

Enrollment

INDIV

Sponsor class

Conditions

Adrenomyeloneuropathy
Adrenoleukodystrophy

Interventions

DRUG: Albumin solution

Sponsor

Pujol, Aurora, M.D.